نتایج جستجو برای: nasopharyngeal cancer

تعداد نتایج: 920710  

Journal: :Oncology 1994
R Stupp R R Weichselbaum E E Vokes

The treatment of head and neck cancer has traditionally consisted of surgery with postoperative radiation therapy. Chemotherapy has been reserved for palliation. In recent years, induction chemotherapy has been shown to allow for larynx preservation in patients with laryngeal or hypopharyngeal cancer. Concomitant chemoradiotherapy has been shown to provide a statistically significant survival b...

Journal: :The oncologist 2010
Whay K Chia Who W Wang Wan T Lim Wai M Tai Li Sun Choon H Thng Yatanar Soe Swee P Yap Eng H Tan Han C Toh

We present a case of a patient with metastatic nasopharyngeal carcinoma who failed two lines of palliative combination chemotherapy and was treated with allogeneic nonmyeloablative stem cell transplantation (NST). This patient achieved a durable tumor response, dramatic relief of his symptoms, and elimination of tumor in his bone marrow-an effect likely achieved via a graft-versus-tumor respons...

2017
Zijian Wu Ying Li

Grifolin, a natural product isolated from the mushroom Albatrellus confluens, has been reported to be a potent anti-cancer agent in nasopharyngeal carcinoma and osteosarcoma. The data obtained in this study revealed that grifolin is capable of inhibiting the growth and invasion of gastric cancer cells by inducing apoptosis and suppressing the ERK1/2 pathway. Our results support the potent utili...

Duc Thuan Lao , Kim Phuong Truong , Thuy Ai Le Huyen ,

Background: Epstein-barr virus nuclear antigen 1 (EBNA1) plays a crucial role in Nasopharyngeal carcinoma (NPC), the most common cancer of head and neck cancer in Asian countries with high incidents. Sequence variations are of high frequency within the functionally important domains of EBNA-1, which have been classified into five subtypes: Phenotype (P)-ala, P-thr, V-val, V-leu and V-pro and ar...

2009
Angela B.Y. Hui Shijun Yue Wei Shi Nehad M. Alajez Emma Ito Simon R. Green Sheelagh Frame Brian O'Sullivan Fei-Fei Liu

Purpose: Seliciclib is a small-molecule cyclin-dependent kinase inhibitor, which has been reported to induce apoptosis and cell cycle arrest in EBV-negative nasopharyngeal carcinoma cell lines. Because most nasopharyngeal carcinoma patients harbor EBV, we proceeded to evaluate the cytotoxic effects of seliciclib in EBV-positive nasopharyngeal carcinoma models. Experimental Design: Cytotoxicity ...

Journal: :European Archives of Oto-Rhino-Laryngology 2010

Journal: :JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY 2012

Journal: :CancerSpectrum Knowledge Environment 2002

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید